您的位置: 首页 > 农业专利 > 详情页

Nanoparticle-based tumor-targeted drug delivery
专利权人:
THE SCRIPPS RESEARCH INSTITUTE
发明人:
REISFELD RALPH A.,XIANG RONG,LUO YUNPING,LIAO DEBBIE,LIU ZE,CHEN TINGMEI,CHEN SI,LU DAN
申请号:
NZ60874811
公开号:
NZ608748A
申请日:
2011.09.02
申请国别(地区):
NZ
年份:
2015
代理人:
摘要:
Provided is a legumain-targeting lipid comprising a lipid bound to a legumain binding moiety wherein the legumain binding moiety comprises an aza-Asn peptide-type legumain inhibitor having a reactive portion of formula (I). Further provided is a legumain-targeting nanoparticle composition comprising lipid nanoparticles comprising the aforementioned legumain-targeting lipid admixed with one or more other micelle or vesicle-forming lipid materials. An anti-cancer agent can be encapsulated in the nanoparticles. The lipid is designed to target anti-cancer agents to tumours which overexpress legumain.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充